A phase II, multi-center, single-arm, global study of MEDI4736 monotherapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN)

Administered By

Contributors

Start/End

  • April 1, 2015 - March 31, 2020